| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/03/1999 | EP0899329A2 DextranaseB gene from Streptococcus pneumoniae |
| 03/03/1999 | EP0898968A1 Antitumor agent comprising a complex of an oxidoreductase and a polymer and a substrate of the enzyme |
| 03/03/1999 | EP0898963A2 Congestive heart failure treatment |
| 03/03/1999 | EP0898896A1 Fat based food products comprising sterols |
| 03/03/1999 | EP0898580A1 Methods and means for inhibition of cdk4 activity |
| 03/03/1999 | EP0898478A1 Stimulation of host defence mechanisms against tumors |
| 03/03/1999 | CN1209876A Isolated tyrosinase derived peptides and uses thereof |
| 03/03/1999 | CN1209840A Noval CREBa phenogen |
| 03/03/1999 | CN1209751A Improved concentrated injection and infusion solutions for intravenous administration |
| 03/03/1999 | CN1209750A Combined pharmaceutical preparation containing LHRH-analogous substances and anti-estrogens for treating gynaecological disorders |
| 03/03/1999 | CN1209748A Nucleoside analogs in combination therapy of herpes simplex infections |
| 03/03/1999 | CN1209747A Modulation of TH1/TH2 cytokine expression by Ribavirin and Ribavirin analogs in activated T-lymphocytes |
| 03/03/1999 | CN1209741A Preparations of non-steroidal analgesics |
| 03/03/1999 | CN1209316A Combined medicinal preparation of sodium/hydrogen exchange-pump inhibitor and medicine for treatment of angiocardiopathy |
| 03/02/1999 | US5877399 Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
| 03/02/1999 | US5877282 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 03/02/1999 | US5877216 Treatment of female sexual dysfunction |
| 03/02/1999 | US5877213 Compositions and methods for therapy and prevention of cancer, AIDS, and anemia |
| 03/02/1999 | US5877203 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/02/1999 | US5877189 Pure isomer |
| 03/02/1999 | US5877185 Therapy for cancer or retrovirus |
| 03/02/1999 | US5877176 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 03/02/1999 | US5877173 Preventing neuronal degeneration in Alzheimer's disease |
| 03/02/1999 | US5877159 The gene may encode, e.g., a vaccine antigen, an therapeutic agent, an immunoregulatory agent or a anti-sense rna or a catalytic rna. |
| 03/02/1999 | US5877155 Exposure of platelets to the molecule (anti-mimotope) in order to modulate adhesion, aggregation, or agglutination of the platelets. |
| 03/02/1999 | US5876963 Human nucleotide pyrophosphohydrolase |
| 03/02/1999 | US5876939 Screening for apoptosis modulators by determining alteration of association between cytoplasmic domain of cell surface protein and other proteins in presence of compound; anticarcinogenic agents |
| 03/02/1999 | US5876923 Screening suppressors which inhibit infected cell protein-4 polypetide by infecting cells with defective alpha-4 gene virus, incubating with compound allowing viral replication, comparing cell pathology |
| 03/02/1999 | US5876920 Screening for vircides and viral suppressors by contacting infected cell with agent, determining if suppression of prenylation of proteins; against hepatitis virus |
| 03/02/1999 | US5876757 Magnesium taurine compound |
| 03/02/1999 | US5876751 Antispasmodic and antinflammatory composition and a process for the manufacture thereof |
| 03/02/1999 | US5876750 Dosage form comprises a laminated wall for maintaining the integrity of the dosage form and of the antiepileptic drug. |
| 03/02/1999 | US5876730 Heparin-binding growth factor (HBGF) polypeptides |
| 03/02/1999 | US5876709 Ophthalmic composition containing active Vitamin D |
| 03/02/1999 | US5876708 Allogeneic and xenogeneic transplantation |
| 03/02/1999 | US5876691 Screening a bacteriophage library; diagnosis of colorectal tumors |
| 03/02/1999 | CA2242315A1 Mecb |
| 03/02/1999 | CA2242252A1 Dexb |
| 03/02/1999 | CA2241417A1 Novel ffh |
| 03/02/1999 | CA1340417C Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same |
| 03/01/1999 | CA2242311A1 Novel compounds |
| 02/28/1999 | CA2246407A1 Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa |
| 02/28/1999 | CA2241424A1 Novel ftsy |
| 02/28/1999 | CA2241400A1 Ftsy |
| 02/27/1999 | CA2245776A1 Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases |
| 02/25/1999 | WO1999009182A2 Rab proteins |
| 02/25/1999 | WO1999009171A1 Ubc7-like ubiquitin-conjugating enzyme |
| 02/25/1999 | WO1999009152A1 Human frezzled-like protein |
| 02/25/1999 | WO1999009063A1 Interleukin-18 binding proteins, their preparation and use |
| 02/25/1999 | WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | WO1999009049A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999009046A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999009005A1 Hiv matrix protein tyrosine position 29 pocket binders |
| 02/25/1999 | WO1999008718A2 Bioresorbable compositions for implantable prostheses |
| 02/25/1999 | WO1999008704A1 Method of protecting against chronic infections |
| 02/25/1999 | WO1999008703A1 Anti-viral treatment with pertussis toxin b oligomer |
| 02/25/1999 | WO1999008697A1 Treatment of congestive heart failure with growth hormone secretagogues |
| 02/25/1999 | WO1999008682A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 02/25/1999 | WO1999008681A1 Inducing neurotransmitter and neuropeptide activity |
| 02/25/1999 | WO1999008676A1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 02/25/1999 | WO1999008671A1 Gaba analogs to prevent and treat gastrointestinal damage |
| 02/25/1999 | WO1999008670A1 Gaba analogs to prevent and treat gastrointestinal damage |
| 02/25/1999 | WO1999008668A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 02/25/1999 | WO1999008658A1 Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
| 02/25/1999 | WO1999008656A1 Antacid composition |
| 02/25/1999 | WO1999008514A1 Compositions containing polyethylene glycol and uses thereof |
| 02/25/1999 | WO1998052582A3 Non-myeloablative tolerogenic treatment |
| 02/25/1999 | WO1998046243A3 Pharmaceutical compositions having appetite suppressant activity |
| 02/25/1999 | WO1998032017A3 Modulators of insulin receptor activity |
| 02/25/1999 | CA2301921A1 Compositions containing polyethylene glycol and uses thereof |
| 02/25/1999 | CA2301292A1 Antacid composition |
| 02/25/1999 | CA2301228A1 Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
| 02/25/1999 | CA2300918A1 Ubc7-like ubiquitin-conjugating enzyme |
| 02/25/1999 | CA2300848A1 Treatment of congestive heart failure with growth hormone secretagogues |
| 02/25/1999 | CA2300801A1 Rab proteins |
| 02/25/1999 | CA2300431A1 Anti-viral treatment with pertussis toxin b oligomer |
| 02/25/1999 | CA2300390A1 Human frezzled-like protein |
| 02/25/1999 | CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | CA2298855A1 Interleukin-18 binding proteins, their preparation and use |
| 02/25/1999 | CA2241430A1 Novel murb |
| 02/25/1999 | CA2241403A1 Murb |
| 02/25/1999 | CA2241392A1 Pigr-2, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2241390A1 Pigrl-1, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2239260A1 Human disintegrin metalloprotease related to drosophila kuz gene |
| 02/24/1999 | EP0897986A2 Aspartic proteinase 5 (ASP5) |
| 02/24/1999 | EP0897981A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897915A1 Quinazolinone conpounds as chemotherapeutic agents |
| 02/24/1999 | EP0897390A1 Human tumor necrosis factor delta and epsilon |
| 02/24/1999 | EP0449968B1 Process for the preparation of human dnase |
| 02/24/1999 | CN1209066A Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restemosis |
| 02/24/1999 | CN1209064A Combination therapy for osteoporosis |
| 02/24/1999 | CN1209058A Aminoguanidine for treating NIDOM |
| 02/24/1999 | CN1209057A Nitric oxide (NO) synthase inhibitor to treat or prevent type II diabetes |
| 02/23/1999 | US5874591 Method for the preparation of (±)-calanolide A and intermediates thereof |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874542 Single chain antibodies specific to VEGF receptors |
| 02/23/1999 | US5874535 Human leptin receptor gene-related protein |
| 02/23/1999 | US5874479 Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |